Procelltech presents the latest version of the company web-site
Procelltech can support preclinical and clinical trials by developing research studies of biomarker (efficacy, potency and safety) through ex vivo and/or in vitro assays.
It is now on-line the new Procelltech’s web-site. Procelltech is a company based in Colleretto Giacosa (Torino,
Italy) whose focus is on regenerative medicine and pre-clinical activities to assess safety and efficacy of new compounds with pharmaceutical activity. Regenerative medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to damage, or congenital defects. This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves.Procelltech wants to be a partner for public and private research institutes (University, Hospitals and Pharma Companies) that are going to build and manage a Cell Factory and/or a Biobanks in accordance to International Standard (Good Manufacturing Practice, cGMP, ICH) and Regulations (EC/1394/2007). To this aim, Procelltech offers GMP compliant Quality Control assays on biotech/cellular products for advanced therapies (e.g. cellular and gene therapy) according to European Pharmacopeia.Also, Procelltech offers cGMP consultancy for designing a cGMP facility eg cGMP Cell Factory, for implementing Quality systems and for drafting and management of regulated documentation.Procelltech can support preclinical and clinical trials by developing research studies of biomarker (efficacy, potency and safety) through ex vivo and/or in vitro assays.Relevant social, scientific and technological changes have led to new needs in health care and therapies. New technologies have allowed impressive results such as use of stem cells for innovative therapies and new methodologies for diagnosis and prognosis of chronic diseases